跳至主要内容
临床试验/ISRCTN18291587
ISRCTN18291587进行中(未招募)Unknown

Inducible Laryngeal Obstruction in adults: developing a standardised non-pharmacological Intervention

niversity of Manchester0 个研究点目标入组 34 人开始时间: 2024年1月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Healthcare professionals:
  • 1. Experienced (defined as holding a regular ILO caseload for >3 years) in assessing, diagnosing and delivering nonpharmacological treatment to adults with ILO
  • Treatment naïve patients:
  • 1. An established diagnosis of ILO based on i) clinical evaluation AND ii) endoscopic visualisation of laryngeal obstruction during a symptomatic episode
  • 2. >18 years old
  • 3. Have not received and completed non-pharmacological / behavioural therapy intervention for ILO
  • Post-treatment patients:
  • 1. An established diagnosis of ILO based on i) clinical evaluation and ii) endoscopic visualisation of laryngeal obstruction during a symptomatic episode
  • 2. >18 years old
  • 3. Have received and completed a non-pharmacological behavioural therapy intervention for ILO

排除标准

  • Healthcare professionals:
  • 1. Healthcare professionals who have no specialist experience in assessing, diagnosing and delivering nonpharmacological treatment to adults with ILO
  • Treatment naïve patients:
  • 1. Have received any previous therapy intervention for ILO, refractory chronic cough or upper airway symptoms (e.g.
  • muscle tension dysphonia, globus pharyngeaous)
  • 2. Have uncontrolled asthma airway inflammation or obstruction (defined as fractional exhaled nitric oxide >50ppb,
  • FEV1/FVC <70%)
  • Post-treatment patients:
  • 1. Have completed a non-pharmacological behavioural therapy intervention for ILO greater than 4 months prior to study
  • 2. Have uncontrolled airway inflammation or obstruction (defined as fractional exhaled nitric oxide >50ppb, FEV1/FVC

研究者

发起方
niversity of Manchester

相似试验